Silo Pharma’s SPU-21 Peptide Shows Positive Results Against Rheumatoid Arthritis
October 16, 2023 08:11 ET
|
Silo Pharma, Inc.
Human tissue study assessed SPU-21’s efficiency, optimization, and binding affinity ENGLEWOOD CLIFFS, NJ, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a...
Praxis Precision Medicines Provides Portfolio Update at 2023 R&D Day
October 02, 2023 13:17 ET
|
Praxis Precision Medicines, Inc.
Positive results from preliminary analysis of PRAX-222 Part 1 showed 44% median reduction in seizures after three doses for SCN2A-gain-of-function pediatric patients Phase 3 (Essential3) program for...
Vyant Bio Announces Adjournment of Special Meeting of Stockholders
September 28, 2023 11:45 ET
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT), today announced that its special meeting of stockholders on September 28, 2023 (the...
Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)
September 28, 2023 06:00 ET
|
Bionomics Ltd
ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. Statistically significant secondary endpoints...
Bionomics Announces Update on the α7 Nicotinic Acetylcholine Receptor (nAChR) Positive Allosteric Modulator (PAM) Collaboration with MSD
September 14, 2023 06:00 ET
|
Bionomics Ltd
Bionomics has collaborated with MSD to identify novel α7 nAChR PAMs suitable for the treatment of cognitive disorders like Alzheimer’s DiseaseBased on the learnings from Bionomics’ candidate BNC375,...
Global Set Top Box Market Size/Share Forecasted to Grow Over USD 32.46 Billion By 2032, at a CAGR of 3.3%: Polaris Market Research
September 11, 2023 09:35 ET
|
Polaris Market Research & Consulting LLP
New York, NY, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “Set Top Box Market Share, Size, Trends, Industry Analysis Report, By Product...
Bionomics Completes Last Patient Last Visit in the Phase 2b ATTUNE Study for Post-Traumatic Stress Disorder (PTSD) and Confirms Expected 2023 Milestones with its Lead Asset BNC210
August 23, 2023 06:00 ET
|
Bionomics Ltd
The last patient last visit has been completed in the Phase 2b ATTUNE study of BNC210 for the treatment of PTSDTopline results from Phase 2b ATTUNE study of BNC210 in patients with PTSD are expected...
Smart Highway Market Size & Share to Surpass $84.6 Billion by 2030 | Vantage Market Research
August 16, 2023 07:31 ET
|
Vantage Market Research
WASHINGTON, Aug. 16, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Smart Highways Market has steadily grown over the years due to the significance of intelligent transportation...
Smart Highways Market to Cross USD 95.09 Billion by 2030 due to Rising Demand for Safety Coupled with Government Initiatives and Investments | By SNS Insider
August 09, 2023 08:54 ET
|
SNS Insider pvt ltd
Pune, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The SNS Insider report indicates that, “The Smart Highways Market had a valuation of $25.47 billion in 2022. Projections suggest that it could reach $95.09...
Quarterly Activities and Cashflow Report
July 31, 2023 06:00 ET
|
Bionomics Ltd
ADELAIDE, Australia, and CAMBRIDGE, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO), (Bionomics or the Company) a clinical-stage biopharmaceutical company...